Ascend Wellness Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	489.52	500.58	561.6	518.59	405.93	332.38
Revenue Growth (YoY)	-10.54%	-10.87%	8.29%	27.76%	22.13%	131.25%
Cost of Revenue	314.52	330.9	377.39	363.47	271.36	196.41
Gross Profit	175	169.68	184.21	155.12	134.56	135.97
Selling, General & Admin	134.65	129.39	144.48	129.43	122.43	106.02
Other Operating Expenses	-	-	-	-22.79	-	-
Operating Expenses	175.7	170.44	179.46	136.17	136.52	116.06
Operating Income	-0.7	-0.76	4.75	18.95	-1.96	19.91
Interest Expense	-60.36	-51.29	-45.26	-36.98	-32.44	-63.99
Other Non Operating Income (Expenses)	1.14	1.49	0.71	3.05	0.76	0.26
EBT Excluding Unusual Items	-59.92	-50.56	-39.81	-14.99	-33.64	-43.82
Merger & Restructuring Charges	-	-	-	-	-0.22	-
Gain (Loss) on Sale of Assets	0.75	0.75	-0.02	0.23	-0.35	-0.61
Legal Settlements	-17	-17	-	-	-5	-36.51
Pretax Income	-76.17	-66.82	-39.82	-14.76	-39.21	-80.94
Income Tax Expense	52.25	51.38	45.17	33.45	41.69	41.72
Earnings From Continuing Operations	-128.43	-118.19	-84.99	-48.21	-80.9	-122.66
Net Income	-128.43	-118.19	-84.99	-48.21	-80.9	-122.66
Net Income to Common	-128.43	-118.19	-84.99	-48.21	-80.9	-122.66
Shares Outstanding (Basic)	203	203	212	199	183	149
Shares Outstanding (Diluted)	203	203	212	199	183	149
Shares Change (YoY)	-4.07%	-4.22%	6.67%	8.60%	22.72%	57.03%
EPS (Basic)	-0.63	-0.58	-0.40	-0.24	-0.44	-0.82
EPS (Diluted)	-0.64	-0.58	-0.40	-0.24	-0.44	-0.82
Free Cash Flow	-12.06	12.04	50.76	51.09	-120	-130.17
Free Cash Flow Per Share	-0.06	0.06	0.24	0.26	-0.65	-0.87
Gross Margin	35.75%	33.90%	32.80%	29.91%	33.15%	40.91%
Operating Margin	-0.14%	-0.15%	0.85%	3.65%	-0.48%	5.99%
Profit Margin	-26.24%	-23.61%	-15.13%	-9.30%	-19.93%	-36.90%
Free Cash Flow Margin	-2.46%	2.41%	9.04%	9.85%	-29.56%	-39.16%
EBITDA	42.24	42.09	41.99	49.71	14.05	30.61
EBITDA Margin	8.63%	8.41%	7.48%	9.59%	3.46%	9.21%
D&A For EBITDA	42.94	42.85	37.24	30.76	16.01	10.7
EBIT	-0.7	-0.76	4.75	18.95	-1.96	19.91
EBIT Margin	-0.14%	-0.15%	0.85%	3.65%	-0.48%	5.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.